TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+13.63%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.76B
AUM Growth
+$122M
(+4.6%)
Cap. Flow
-$186M
Cap. Flow
% of AUM
-6.75%
Top 10 Holdings %
Top 10 Hldgs %
38.62%
Holding
217
New
37
Increased
33
Reduced
47
Closed
5
Top Buys
| 1 |
Zoetis
ZTS
|
+$17.5M |
| 2 |
Johnson & Johnson
JNJ
|
+$14.4M |
| 3 |
Elevance Health
ELV
|
+$8.36M |
| 4 |
Novo Nordisk
NVO
|
+$7.83M |
| 5 |
Thermo Fisher Scientific
TMO
|
+$6.76M |
Top Sells
| 1 |
Merck
MRK
|
+$45.3M |
| 2 |
Pfizer
PFE
|
+$44.3M |
| 3 |
Vertex Pharmaceuticals
VRTX
|
+$33.4M |
| 4 |
UnitedHealth
UNH
|
+$21.5M |
| 5 |
Eli Lilly
LLY
|
+$18.6M |
Sector Composition
| 1 | Healthcare | 93.74% |
| 2 | Real Estate | 2.75% |
| 3 | Financials | 0.62% |
